| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/22/2007 | US20070066835 Process for the synthesis of amorphous atorvastain calcium |
| 03/22/2007 | US20070066823 CCR9 inhibitors and methods of use thereof |
| 03/22/2007 | US20070066676 2-(2,3,3a,8b-Tetrahydro-1H-cyclopenta[b]indol-4-yl-substituted acetamides, acetonitriles and ethylamines as intermediates |
| 03/22/2007 | US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis |
| 03/22/2007 | US20070066614 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 03/22/2007 | US20070066600 Compounds |
| 03/22/2007 | US20070066599 New compounds |
| 03/22/2007 | US20070066598 Compounds |
| 03/22/2007 | US20070066590 Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolism |
| 03/22/2007 | US20070066576 Compounds which modulate 2OG (2-oxoglutarate) dependent oxygenases, in particular prolyl hydroxylases; may be useful as modulators of HIF (hypoxia inducible factor) alpha (HIF- alpha ) prolyl hydroxylase; for example, analogues of 2-oxoglutarate, N-phenoxy-acetyl-(L)-alanine-hydroxamide |
| 03/22/2007 | US20070066528 Methods and compositions for treating polycystic ovary syndrome |
| 03/22/2007 | US20070065941 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
| 03/22/2007 | US20070065915 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 03/22/2007 | US20070065493 External patch containing estrogen and/or progestogen |
| 03/22/2007 | US20070065380 provitamin C is prepared from Lycium fruit extract; decomposed in the body to produce vitamin C; improved stability in the body and prolonged life in the body; bioavailability; vitamin C-fortified food; apply to skin protecting from ultraviolet damage, wrinkles and aging |
| 03/22/2007 | US20070065369 Bioavailability; delivery to deep lung; lipid based microstructure; rapid release and absorption |
| 03/22/2007 | DE202005017532U1 Zusammensetzung mit cholesterolsenkender Wirkung Composition with cholesterolsenkender effect |
| 03/22/2007 | CA2623831A1 An extract from xylocarpus useful for the treatment of diabetes and dyslipidemia |
| 03/22/2007 | CA2622608A1 Dipeptidyl peptidase inhibitors for treating diabetes |
| 03/22/2007 | CA2622605A1 Heterocycle compound, and production process and application thereof |
| 03/22/2007 | CA2622597A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 03/22/2007 | CA2622518A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
| 03/22/2007 | CA2622472A1 Dipeptidyl peptidase inhibitors for treating diabetes |
| 03/22/2007 | CA2621949A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
| 03/22/2007 | CA2621368A1 Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels |
| 03/22/2007 | CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity |
| 03/22/2007 | CA2620370A1 Extended release pharmaceutical composition of metformin and a process for producing it |
| 03/22/2007 | CA2620296A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 03/22/2007 | CA2612769A1 Improved pharmaceutical composition containing hmg-coa reductase inhibitor and method for the preparation thereof |
| 03/21/2007 | EP1764370A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/21/2007 | EP1764366A2 Thrombin receptor antagonists |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1764134A2 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 03/21/2007 | EP1764110A1 Compositions comprising an insulin sensitivity enhancer and a biguanide |
| 03/21/2007 | EP1764109A1 Agonist antibodies that bind to the TWEAK receptor Fn14, thereby modulating adiposity-associated phenotypes, and their use in therapy |
| 03/21/2007 | EP1764091A2 Improvements in or relating to amphoteric liposomes |
| 03/21/2007 | EP1763517A2 Pyrimidine derivatives as 11beta-hsd1 inhibitors |
| 03/21/2007 | EP1763511A1 Phenoxyacetic acid derivatives as ppar agonists |
| 03/21/2007 | EP1763502A1 Novel hexafluoroisopropanol derivatives |
| 03/21/2007 | EP1763359A2 Use of the pregnane glycosides in the treatment/management of obesity, obesity-related and other disorders |
| 03/21/2007 | EP1763350A1 Nicotinamide derivatives and their use as therapeutic agents |
| 03/21/2007 | EP1633377B1 A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 03/21/2007 | EP1487821B1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases |
| 03/21/2007 | EP1451177B1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 03/21/2007 | EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 03/21/2007 | EP1397492B1 Modified and stabilized gdf propeptides and uses thereof |
| 03/21/2007 | EP1361867B1 Fibrate-statin combinations with reduced fed-fasted effects |
| 03/21/2007 | EP1303305B1 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure |
| 03/21/2007 | EP1206485B1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/21/2007 | EP1049717B1 Antibodies against human il-12 |
| 03/21/2007 | CN1934122A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 03/21/2007 | CN1934105A Aryl-substituted heterocycles, process for their preparation and their use as medicaments |
| 03/21/2007 | CN1934103A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 03/21/2007 | CN1934100A Substituted quinazoline or pyridopyrimidine derivative |
| 03/21/2007 | CN1934099A N-piperidine derivates as CCR3 modulators |
| 03/21/2007 | CN1934090A Substituted n-cyclohexyl imidazolinones having an mch-modulatory effect |
| 03/21/2007 | CN1933848A Y2 selective receptor agonists for therapeutic interventions |
| 03/21/2007 | CN1933846A Acerola leaf extract-containing blood sugar level increase inhibitor and age formation inhibitor, and food containing them |
| 03/21/2007 | CN1933845A Algin oligose and derivative thereof and producing method and use thereof |
| 03/21/2007 | CN1933824A Coenzyme q compositions persisting in blood |
| 03/21/2007 | CN1933823A Use of renin inhibitors in therapy |
| 03/21/2007 | CN1933739A Compositions and methods for reducing or preventing obesity |
| 03/21/2007 | CN1931874A Prepn process, medicine prepn and medicinal use of ginseng glycopeptide |
| 03/21/2007 | CN1931859A New fused imidazole derivative |
| 03/21/2007 | CN1931362A Application of human urokinase-type peptidase in preparing medicine for treating diabetes combined cerebral infraction |
| 03/21/2007 | CN1931361A Prepn process of blood-nourishing and iron-replenishing health nutrient |
| 03/21/2007 | CN1931360A Double timephase neo-insulin zinc injection (30%) and its prepn process |
| 03/21/2007 | CN1931348A Hyperlipemia treating Chinese medicine prepn |
| 03/21/2007 | CN1931335A Nutritious powder with functions of reducing lipid and slimming |
| 03/21/2007 | CN1931334A Diabetes treating medicine |
| 03/21/2007 | CN1931333A Bagged tea for treating diabetes |
| 03/21/2007 | CN1931327A Blood lipid lowering medicine powder |
| 03/21/2007 | CN1931326A Apoplexy treating capsule |
| 03/21/2007 | CN1931324A New method of treating diabetes with gypsum, anemarrhena rhizome and oriental water plantain rhizome for clearing away heat and nourishing Yin |
| 03/21/2007 | CN1931318A Chines medicine composition for treating children rickets and other acalcicosis symptoms and its prepn process |
| 03/21/2007 | CN1931316A Xiaokezhinian capsule for treating diabetet, hyperlipemia and likes |
| 03/21/2007 | CN1931307A Chinese onion bulb soft capsule and its prepn process and use |
| 03/21/2007 | CN1931289A Deer fetus-pearl capsule |
| 03/21/2007 | CN1931281A Prepn process of capsule for lowering blood lipid, blood sugar and blood pressure |
| 03/21/2007 | CN1931261A Blood pressure and blood lipid lowering capsule and its prepn process |
| 03/21/2007 | CN1931260A Hyperlipemia treating oral liquid |
| 03/21/2007 | CN1931254A Diabetes treating medicine |
| 03/21/2007 | CN1931234A Medicine composition of red sage and puerarin |
| 03/21/2007 | CN1931233A Medicine composition of red sage and epimedium for treating cardiac and cerebral vascular diseases |
| 03/21/2007 | CN1931232A Oil-in-water nanometer perilla seed oil emulsion oral liquid and its prepn process |
| 03/21/2007 | CN1931219A Gynostemma pentaphylla micro emulsion medicine and its prepn |
| 03/21/2007 | CN1931210A 鹿骨钙 Deer osteocalcin |
| 03/21/2007 | CN1931207A Gymnema sylvestre total saponin inclusion compound and its prepn process |
| 03/21/2007 | CN1931192A Eel oil extract and its extraction process and blood fat reducing health product |
| 03/21/2007 | CN1931184A Massive dose calcium replenisher tablet for treating hyperosteogeny and its prepn |
| 03/21/2007 | CN1931182A Health food for preventing and treating cardiac and cerebral vascular diseases and its production process |
| 03/21/2007 | CN1931176A Aescin medicine composition and its prepn process and use |
| 03/21/2007 | CN1306020C Polyporus frondosus oral liquor and its production method |
| 03/21/2007 | CN1305897C New peptide compounds, process for their preparation and pharmaceutical compositions containing them |
| 03/21/2007 | CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 03/21/2007 | CN1305853C Process for the manufacture of HMG-coa reductase inhibitors |
| 03/21/2007 | CN1305852C Diaryl ethers as opioid receptor antagonist |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/21/2007 | CN1305848C 2,3-dihydro-isoindol-1-ones with MAO-B inhibiting activity |
| 03/21/2007 | CN1305847C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |